ESR1 and neoplasm: Alternatively, the use of a combination of markers such as ER, PR, HER-2 and Ki67 together with disease characteristics such as tumor size and lymph node involvment has been somewhat useful in providing a risk of recurrence assessment for breast cancer patients at primary diagnosis.